Skip to main content
OpenTrials

Clinical trial condition

Cystic Fibrosis, Homozygous for the F508del CFTR Mutation

Explore clinical trials studying Cystic Fibrosis, Homozygous for the F508del CFTR Mutation. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Cystic Fibrosis, Homozygous for the F508del CFTR Mutation trial results

Completed

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

NCT01807949

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis, Homozygous for the F508del CFTR Mutation, +6 more
Locations
  • Oakland, California, United States
  • Sacramento, California, United States
  • Aurora, Colorado, United States
  • Hartford, Connecticut, United States
View all 82 locations
View Trial Details
Completed

A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation

NCT01807923

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Cystic Fibrosis, Homozygous for the F508del CFTR Mutation, +6 more
Locations
  • Birmingham, Alabama, United States
  • Anchorage, Alaska, United States
  • Tucson, Arizona, United States
  • Little Rock, Arkansas, United States
View all 89 locations
View Trial Details

Related conditions